BLACKROCK HEALTH SCIENCS TR's ticker is BMEZ and the CUSIP is 09260E105. A total of 68 filers reported holding BLACKROCK HEALTH SCIENCS TR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $144,100 | -12.2% | 10,000 | 0.0% | 0.00% | – |
| Q2 2023 | $164,200 | -25.0% | 10,000 | -23.7% | 0.00% | – |
| Q1 2023 | $219,072 | +42.0% | 13,110 | +31.1% | 0.00% | – |
| Q4 2022 | $154,308 | +3.6% | 10,001 | +0.0% | 0.00% | – |
| Q3 2022 | $149,000 | -9.1% | 10,000 | 0.0% | 0.00% | – |
| Q2 2022 | $164,000 | -18.4% | 10,000 | 0.0% | 0.00% | – |
| Q1 2022 | $201,000 | -20.9% | 10,000 | 0.0% | 0.00% | – |
| Q4 2021 | $254,000 | -5.9% | 10,000 | 0.0% | 0.00% | – |
| Q3 2021 | $270,000 | -6.6% | 10,000 | 0.0% | 0.00% | – |
| Q2 2021 | $289,000 | +9.9% | 10,000 | 0.0% | 0.00% | – |
| Q1 2021 | $263,000 | -8.4% | 10,000 | 0.0% | 0.00% | – |
| Q4 2020 | $287,000 | +20.1% | 10,000 | 0.0% | 0.00% | – |
| Q3 2020 | $239,000 | +14.4% | 10,000 | 0.0% | 0.00% | – |
| Q2 2020 | $209,000 | +16.8% | 10,000 | 0.0% | 0.00% | – |
| Q1 2020 | $179,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saba Capital Management, L.P. | 8,347,664 | $120,289,838 | 2.89% |
| Quantedge Capital Pte Ltd | 254,226 | $3,663,397 | 2.00% |
| 1607 Capital Partners, LLC | 1,573,781 | $22,678,184 | 1.70% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 1,684,864 | $24,278,890 | 1.26% |
| EPIQ PARTNERS, LLC | 103,000 | $1,484,231 | 1.12% |
| Almitas Capital LLC | 104,194 | $1,501,436 | 0.72% |
| Thomas J. Herzfeld Advisors, Inc. | 103,500 | $1,491,435 | 0.58% |
| Matisse Capital | 51,296 | $739,175 | 0.52% |
| Atlas Wealth LLC | 176,669 | $2,545,800 | 0.48% |
| Karpus Management, Inc. | 958,125 | $13,806,581 | 0.46% |